- From: D.W.Chadwick <info@verifiablecredentials.info>
- Date: Wed, 8 Apr 2020 17:22:16 +1200
- To: Alex Puig <alex@caelumlabs.com>
- Cc: Adrian Gropper <agropper@healthurl.com>, Moses Ma <moses.ma@futurelabconsulting.com>, Christopher Allen <ChristopherA@lifewithalacrity.com>, Credentials Community Group <public-credentials@w3.org>
Hi Alex
here is one for you, without the proof, which is not needed for JWT
{
"@context": [
"https://www.w3.org/2018/credentials/v1",
"https://www.nhs.org/VCcontext/v1"
],
"id": "https://nhs.org/credentials/3732",
"type": ["VerifiableCredential", "Covid19Immunity"],
"credentialSubject": {
"id": "did:key:jwt:ebfeb1f712ebc6f1c276e12ec21",
"issuanceDate": "2020-04-01T19:23:24Z",
"expirationDate": "2020-04-01T19:33:24Z",
"covid19ImmunityCert": {
"name": "David Chadwick",
"dateOfBirth": "01/01/1980",
"dateOfTest": "02/04/2020",
"testNumber": "376012345612345",
"testResult": "scientific details here",
"validUntil": "01/10/2020"
}
}
}
Any help with filling in the testResult would be very useful
Kind regards
David
On 08/04/2020 16:34, Alex Puig wrote:
> For now, a VC example in JSON would do the job.
>
> Anyway, we are working with a well known epidemiologist, who can help
> us on this.
>
> Alex
>
> El mié., 8 abr. 2020 a las 6:32, D.W.Chadwick
> (<info@verifiablecredentials.info
> <mailto:info@verifiablecredentials.info>>) escribió:
>
> Hi Alex
>
> do you want a VC example in JSON, or a signed example using JWT?
> These
> are the only ones I have. If you want a ZKP or JSON-LD signed one you
> will need to ask someone else.
>
> Note that the example we are using is not a medically correct one,
> but
> rather is a template that will need to be completed with medical
> details
> once these have been standardised. Perhaps Adrian might be able to
> fill
> in more details?
>
> kind regards
>
> David
>
> On 08/04/2020 15:58, Alex Puig wrote:
> > This is relevant to me.
> >
> > We are working on an implementation of
> > https://github.com/DP-3T/documents using Zenroom.
> >
> > An immunity credential example would help us.
> >
> > Alex
> >
> > El mar., 7 abr. 2020 a las 23:27, Adrian Gropper
> > (<agropper@healthurl.com <mailto:agropper@healthurl.com>
> <mailto:agropper@healthurl.com <mailto:agropper@healthurl.com>>>)
> escribió:
> >
> > HT to Juan C.
> > https://unherd.com/2020/04/how-far-away-are-immunity-passports/
> >
> > I would ask: IWhat is the role of VC relative to local or
> > decentralized governance to solving this issue?
> >
> > - Adrian
> >
> >
> > On Tue, Apr 7, 2020 at 3:10 PM D.W.Chadwick
> > <info@verifiablecredentials.info
> <mailto:info@verifiablecredentials.info>
> > <mailto:info@verifiablecredentials.info
> <mailto:info@verifiablecredentials.info>>> wrote:
> >
> > Hi Moses
> >
> > over the last week or so we have developed a proof of
> concept
> > COVID-19
> > Immunity Certificate application demonstrator built on our
> > application
> > independent verifiable credential middleware. We would
> like to
> > participate in challenge (1) headed by Victoriano. I am
> > currently in the
> > process of making a video of our demo
> >
> > Kind regards
> >
> > David
> >
> > On 08/04/2020 06:51, Moses Ma wrote:
> > > Hi Christopher et al,
> > >
> > > You're absolutely right. This is why we have
> recruited: Dr. Ab
> > > Osterhaus to join our team - he is one of the world's
> > leading experts
> > > in coronaviruses, and his team was first to sequence the
> > SARS virus,
> > > Dr. Tony Cox - a data scientist who specializes in
> > epidemiology, and
> > > Triall.io - a clinical research organization that has run
> > over 30
> > > Phase I-IV trials and is the developer of the first
> > blockchain tool
> > > for clinical trials. All of our proposed pilots will
> adhere to
> > > clinical research methodologies that preserve patient
> > privacy and
> > > insure validated data production.
> > >
> > > However, what we could use more of are privacy experts who
> > can quickly
> > > produce innovative working solutions.
> > >
> > > Two challenges we've identified are: (1) the use of
> verifiable
> > > credentials to serve as digital certificates of immunity,
> > and (2) the
> > > possibility of developing interoperable contact
> managers and
> > globally
> > > unique IDs to enable international travel. A big thanks to
> > Victoriano
> > > Giralt for stepping up to manage the first one, but I
> think
> > we still
> > > need to find a MacGyvered approach to solving the
> second...
> > in a way
> > > that has a low barrier to federation and adoption. To be
> > brutally
> > > honest, we are triaging a solution, and we need to see
> > reality clearly
> > > as to whether DIDs can add value short term.
> > >
> > > If you'd like to work on these sub-projects, please let me
> > know.
> > > Again, this is an action-primary team that will need
> to deliver
> > > software on an super-agile basis.
> > >
> > > Anyway, I promised to share the recording of our first
> call
> > so you
> > > know what we're up to, and you can find it here:
> > >
> >
> https://www.dropbox.com/s/rqhpum88k28usti/Zoom-DefenderDIDcall-040620.mp4?dl=0
> > >
> > > Finally, I'll try to make time for CCG calls, but I'm
> getting
> > > exponentially busier these days.
> > >
> > >
> > > Stay healthy everyone!
> > >
> > > Moses
> > >
> > >
> > > PS, thisis a very interesting article about user
> acceptance
> > of contact
> > > managers:https://045.medsci.ox.ac.uk/user-acceptance -
> > respondents
> > > were most concerned about “government using the app as an
> > excuse to
> > > increase surveillance after the epidemic”.
> > >
> > >
> > > <https://045.medsci.ox.ac.uk/user-acceptance>
> > >
> > > On 4/7/20 10:19 AM, Christopher Allen wrote:
> > >> As was discussed briefly in the call today, if we are
> going
> > to talk
> > >> about #Covid19 technology solutions, we must partner with
> > health &
> > >> epidemiological experts to do it right.
> > >>
> > >> For instance, it has been proposed that we support some
> > kind of
> > >> digital immunity certificate. Even if we ignore its
> possible
> > >> human-rights & privacy risks, it can have still have
> risky
> > public
> > >> health care choices:
> > >>
> > >>
> https://unherd.com/2020/04/how-far-away-are-immunity-passports/
> > >>
> > >> “If you issue immunity passports on this basis, /barely a
> > third /of
> > >> the people you give them to will actually be immune.
> > “There’s nothing
> > >> peculiar about this statistically,” Kevin McConway, an
> > emeritus
> > >> professor of statistics at the Open University, told me.
> > “It’s just
> > >> Bayes’ theorem
> > <https://en.wikipedia.org/wiki/Bayes%27_theorem>.” The
> > >> likelihood of you having had Covid-19, if you’ve had a
> > positive test,
> > >> depends not just on the accuracy of the test but on the
> > prevalence in
> > >> the population you’re looking at.
> > >> …
> > >> In the end, that’s going to be a horribly cold-blooded
> > calculation.
> > >> If you let people out when they’re 90% likely to be
> immune,
> > that
> > >> means one person in 10 is going to be at risk of
> getting and
> > >> spreading the disease. Is that risk a price worth paying
> > for reducing
> > >> the real costs (economic, social, physical, mental) of
> > isolation? I
> > >> don’t know and I’m glad I don’t have to work it out. But
> > someone has
> > >> to. And they’ll have to start by getting a reasonably
> > effective test,
> > >> and testing hundreds of thousands of people, to see how
> > many of us
> > >> have had it.”
> > >>
> > >> — Christopher Allen
> > >
> > >
> > > --
> > >
> > > *Moses Ma | Managing Partner*
> > >
> > > moses.ma@futurelabconsulting.com
> <mailto:moses.ma@futurelabconsulting.com>
> > <mailto:moses.ma@futurelabconsulting.com
> <mailto:moses.ma@futurelabconsulting.com>> | moses@ngenven.com
> <mailto:moses@ngenven.com>
> > <mailto:moses@ngenven.com <mailto:moses@ngenven.com>>
> > >
> > > v+1.415.568.1068 | skype mosesma |
> /linktr.ee/moses.tao/ <http://linktr.ee/moses.tao/>
> > <http://linktr.ee/moses.tao/>
> > > <http://linktr.ee/moses.tao>
> > >
> > > FutureLab provides strategy, ideation and technology for
> > breakthrough
> > > innovation and third generation blockchains.
> > >
> > > Learn more at /www.futurelabconsulting.com/
> <http://www.futurelabconsulting.com/>
> > <http://www.futurelabconsulting.com/>
> > > <http://futurelabconsulting.com>. For calendar invites,
> > please cc:
> > > mosesma@gmail.com <mailto:mosesma@gmail.com>
> <mailto:mosesma@gmail.com <mailto:mosesma@gmail.com>>
> > >
> > >
> > > Or whet your appetite by reading /Agile Innovation/
> > >
> >
> <http://www.amazon.com/Agile-Innovation-Revolutionary-Accelerate-Engagement/dp/B00SSRSZ9A>
> >
> > > | /Quantum Design Sprint/
> > >
> >
> <https://www.amazon.com/Quantum-Design-Sprint-Application-Disruptive/dp/1799143864>
> >
> > > | my blog at /psychologytoday.com/
> <http://psychologytoday.com/>
> > <http://psychologytoday.com/>
> > > <http://www.psychologytoday.com/blog/the-tao-innovation>.
> > >
> > > NOTICE TO RECIPIENT: THIS E-MAIL IS MEANT FOR ONLY THE
> INTENDED
> > > RECIPIENT OF THE TRANSMISSION. IF YOU RECEIVED THIS E-MAIL
> > IN ERROR,
> > > ANY REVIEW, USE, DISSEMINATION, DISTRIBUTION, OR
> COPYING OF
> > THIS
> > > E-MAIL IS STRICTLY PROHIBITED. PLEASE NOTIFY THE SENDER
> > IMMEDIATELY OF
> > > THE ERROR BY RETURN E-MAIL AND PLEASE DELETE THIS MESSAGE
> > FROM YOUR
> > > SYSTEM. THIS EMAIL SHOULD NOT BE CONSIDERED BINDING;
> HARD COPY
> > > DOCUMENTS ARE REQUIRED TO CREATE LEGALLY BINDING
> > COMMITMENTS. FOR
> > > CALENDAR INVITES, PLEASE CC: MOSESMA@GMAIL.COM
> <mailto:MOSESMA@GMAIL.COM>
> > <mailto:MOSESMA@GMAIL.COM <mailto:MOSESMA@GMAIL.COM>>
> > >
> >
> >
> >
> > --
> >
> > Alex Puig
> >
> > CTO
> >
> > +34 678544357
> >
> > alex@caelumlabs.com <mailto:alex@caelumlabs.com>
> <mailto:alex@caelumlabs.com <mailto:alex@caelumlabs.com>>
> >
> > Follow us!Twitter <https://twitter.com/caelumlabs>|
> >
> > linkedin <https://www.linkedin.com/company/caelumlabs/>| Newsletter
> > <http://newsletter.caelumlabs.com/>|Gitlab
> <https://gitlab.com/caelumlabs>
> >
> > IMPORTANT: The contents of this email and any attachments are
> > confidential. It is strictly forbidden to share any part of this
> > message with any third party, without a written consent of the
> sender.
> > If you received this message by mistake, please reply to this
> message
> > and follow with its deletion, so that we can ensure such a mistake
> > does not occur in the future.
> >
> > *
> >
> > *
>
>
>
> --
>
> Alex Puig
>
> CTO
>
> +34 678544357
>
> alex@caelumlabs.com <mailto:alex@caelumlabs.com>
>
> Follow us!Twitter <https://twitter.com/caelumlabs>|
>
> linkedin <https://www.linkedin.com/company/caelumlabs/>| Newsletter
> <http://newsletter.caelumlabs.com/>|Gitlab <https://gitlab.com/caelumlabs>
>
> IMPORTANT: The contents of this email and any attachments are
> confidential. It is strictly forbidden to share any part of this
> message with any third party, without a written consent of the sender.
> If you received this message by mistake, please reply to this message
> and follow with its deletion, so that we can ensure such a mistake
> does not occur in the future.
>
> *
>
> *
Received on Wednesday, 8 April 2020 05:22:40 UTC